Abbott to Pay $385M to Settle Contaminated Infant Formula Claims

Abbott agreed to pay about $385 million to settle claims it sold contaminated infant formula. The settlement resolves litigation over alleged contamination, though details on scope and admission of liability remain unclear. This marks a significant financial and reputational cost for Abbott, potentially affecting its market position and regulatory scrutiny.